BIOMARKER:

FANCA mutation

Entrez ID:

Related biomarkers:

‹

›

FANCA mutation FANCA mutation	Prostate Cancer Prostate Cancer	FANCA mutation FANCA mutation	Prostate Cancer Prostate Cancer	rucaparib Sensitive: C2 – Inclusion Criteria	rucaparib Sensitive: C2 – Inclusion Criteria
FANCA mutation FANCA mutation	Prostate Cancer Prostate Cancer	FANCA mutation FANCA mutation	Prostate Cancer Prostate Cancer	PARP inhibitor Sensitive: C3 – Early Trials	PARP inhibitor Sensitive: C3 – Early Trials
FANCA mutation FANCA mutation	HER2 Negative Breast Cancer HER2 Negative Breast Cancer	FANCA mutation FANCA mutation	HER2 Negative Breast Cancer HER2 Negative Breast Cancer	talazoparib Sensitive: C3 – Early Trials	talazoparib Sensitive: C3 – Early Trials
FANCA mutation FANCA mutation	Colorectal Cancer CRC	FANCA mutation FANCA mutation	Colorectal Cancer CRC	sintilimab + fruquintinib Resistant: C3 – Early Trials	sintilimab + fruquintinib Resistant: C3 – Early Trials
FANCA mutation FANCA mutation	Prostate Cancer Prostate Cancer	FANCA mutation FANCA mutation	Prostate Cancer Prostate Cancer	rucaparib + copanlisib Sensitive: C3 – Early Trials	rucaparib + copanlisib Sensitive: C3 – Early Trials
FANCA mutation FANCA mutation	Ovarian Cancer Ovarian Cancer	FANCA mutation FANCA mutation	Ovarian Cancer Ovarian Cancer	niraparib Sensitive: C4 – Case Studies	niraparib Sensitive: C4 – Case Studies